Retail Clinics

BOSTON — InhalerWear on Tuesday announced its launch of a neoprene cover for inhalers that will help make carrying around an inhaler “trendy and cool” to children and teenagers. The new inhaler can be clipped to a backpack, purse or belt loop.

"We started InhalerWear because we knew the challenge facing parents was not in getting their kids to use their inhaler, but to get them to carry their inhalers with them at all times,” stated co-founder Rob Fiore.

ST. PAUL, Minn. — A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

NEW YORK — Consumers that seek timely and detailed information about product recalls look to multiple resources, according to a new Deloitte survey.

ATLANTA — The Centers for Disease Control and Prevention is participating in a new docudrama that debuts on Animal Planet beginning Friday at 9 p.m., the agency announced earlier this week.

Animal Planet has ordered six episodes of the new series “Killer Outbreaks.” Each episode features potentially deadly viruses and includes commentary from CDC experts and victims of the outbreaks. "Killer Outbreaks" began production in March 2010, and in total, producers interviewed 43 subject matter experts from across the agency.

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

Takeda announced the launch of Edarbi (azilsartan medoxomil), which the Food and Drug Administration approved on Feb. 25 as a once-daily pill for hypertension.

JOHNSON CITY, N.Y. — A Native American tribal clinic in Redding, Calif., that fills some 300 prescriptions per day has adopted a pharmacy automation system made by Innovation, the company said Friday.

HYDERABAD, India — The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.

Dr. Reddy's fexofenadine HCl tablets are bioequivalent versions of Sanofi-Aventis’ Allegra, which received Rx-to-OTC switch approval from the FDA in January.

The fexofenadine HCl Rx market had branded and generic sales of approximately $452 million for the 12 months ended last December, according to IMS Health.

BRENTWOOD, Tenn. ­— The Little Clinic has announced the appointment of Kenneth Patric as its new chief medical officer, providing medical oversight and management, and overseeing the development and implementation, of new clinical programs and initiatives for The Little Clinic on a national level.